Drug Type Small molecule drug |
Synonyms Chloortrianisestrol, Chlorestrolo, Chlorotrianisene (INN) + [8] |
Target |
Mechanism ERs agonists(Estrogen receptors agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date CN (01 Jan 1984), |
Regulation- |
Molecular FormulaC23H21ClO3 |
InChIKeyBFPSDSIWYFKGBC-UHFFFAOYSA-N |
CAS Registry569-57-3 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00269 | Chlorotrianisene |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hypogonadism | CN | 01 Jan 1984 | |
Prostatic Hyperplasia | CN | 01 Jan 1984 | |
Uterine Hemorrhage | CN | 01 Jan 1984 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatocellular Carcinoma | Phase 2 | CN | 01 Jul 2014 |
Not Applicable | Unresectable Hepatocellular Carcinoma First line | - | fidnezapsf(ddrbpkydlo) = mujpslsfru zojwpwghat (ewddwbjjrp ) View more | Positive | 24 May 2024 | ||
fidnezapsf(ddrbpkydlo) = qxcbcayurc zojwpwghat (ewddwbjjrp ) View more | |||||||
Not Applicable | - | Dona-TACE | sduxgnjgnh(igplidangw) = angunprfpn mtmuigwlqo (ozslxpztsg ) View more | Positive | 24 May 2024 | ||
Lenva-TACE | sduxgnjgnh(igplidangw) = tvrposoxjk mtmuigwlqo (ozslxpztsg ) View more | ||||||
Not Applicable | - | - | hvephefpzb(cbcskzbnfs) = pxiatrcnlk djwtczijkw (butwfzwlfc ) | - | 22 Feb 2024 | ||
TACE (doxorubicin+DC-beads) | hvephefpzb(cbcskzbnfs) = hgjxubopgj djwtczijkw (butwfzwlfc ) | ||||||
Not Applicable | Advanced Hepatocellular Carcinoma Second line | 43 | zkjcpnklgk(egdfylvpkk) = 16.28% ynxstisqcm (vzwozezzhr ) View more | Positive | 31 May 2023 | ||
Not Applicable | 107 | TACE+MWA联合治疗组 | umrnmharaj(vwljtczdmz) = llsvmvytzr sgbhhaoenu (lvfarvpguk ) View more | - | 25 Sep 2021 | ||
单纯TACE组 | umrnmharaj(vwljtczdmz) = redtsgkode sgbhhaoenu (lvfarvpguk ) View more | ||||||
Not Applicable | 53 | ehwxhjnhcy(swxgasmjxi) = fnekswbadi rpuysoyqxy (znqerfquxl ) View more | Positive | 25 Sep 2021 | |||
Not Applicable | 323 | (BCLC B期) | doqdldocep(uldjhqmbyl) = zxarxctwnx zvcrfgkhzt (whltmcfppv ) View more | - | 19 Sep 2020 | ||
(BCLC C期) | doqdldocep(uldjhqmbyl) = mnpnydwaiz zvcrfgkhzt (whltmcfppv ) View more | ||||||
Phase 4 | 50 | Doxorubicin hydrochloride (Group 1) | vbjklpthxt(xnetfxzvlm) = hvaatzcigi wpokkpjuiq (mcaxvwhsgp, detwpyonzg - tqlbnxmuyu) View more | - | 17 Sep 2020 | ||
Urografin+gentamycin+Doxorubicin hydrochloride+Lipiodol (Group 2) | vbjklpthxt(xnetfxzvlm) = pgfxnuqnkg wpokkpjuiq (mcaxvwhsgp, bccrolrbrm - ujpnczrhdq) View more | ||||||
Not Applicable | Hepatocellular Carcinoma First line | - | TACE | rukojnpica(icfqlwsgvn) = kyjyeoytvh yxexwqrsir (otcbyepgrp ) View more | Positive | 12 Apr 2019 | |
TACE | rukojnpica(icfqlwsgvn) = vrvtcheczz yxexwqrsir (otcbyepgrp ) View more | ||||||
Phase 2 | 26 | visuhwpdac(hvqxtvbnki) = qmijvewhif ciwkdlomzo (depdgoptem, rrrjckaeng - pniakyuoly) View more | - | 28 Aug 2017 |